Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Common Equity (2018 - 2025)

Historic Common Equity for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $135.5 million.

  • Viemed Healthcare's Common Equity rose 686.15% to $135.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.5 million, marking a year-over-year increase of 686.15%. This contributed to the annual value of $133.3 million for FY2024, which is 1703.85% up from last year.
  • As of Q3 2025, Viemed Healthcare's Common Equity stood at $135.5 million, which was up 686.15% from $141.6 million recorded in Q2 2025.
  • Viemed Healthcare's 5-year Common Equity high stood at $141.6 million for Q2 2025, and its period low was $83.4 million during Q1 2021.
  • Its 5-year average for Common Equity is $109.1 million, with a median of $104.5 million in 2023.
  • As far as peak fluctuations go, Viemed Healthcare's Common Equity skyrocketed by 7095.87% in 2021, and later soared by 239.82% in 2022.
  • Quarter analysis of 5 years shows Viemed Healthcare's Common Equity stood at $94.8 million in 2021, then rose by 2.4% to $97.1 million in 2022, then increased by 17.3% to $113.9 million in 2023, then increased by 17.04% to $133.3 million in 2024, then increased by 1.65% to $135.5 million in 2025.
  • Its last three reported values are $135.5 million in Q3 2025, $141.6 million for Q2 2025, and $136.7 million during Q1 2025.